Skip to the main content

Review article

https://doi.org/10.37797/ig.43.2.2

Four decades of hepatitis B vaccination: from universal immunization to new vaccine generations and challenges of mutant variants

Marija Špelić orcid id orcid.org/0009-0000-7106-8422 ; Župančić Pharmacies Health Institution, Croatia *

* Corresponding author.


Full text: croatian pdf 525 Kb

page 38-45

downloads: 0

cite


Abstract

Hepatitis B virus (HBV) infection represents a significant global public health problem. HBV infection is a major cause of chronic liver disease and the leading cause of hepatocellular carcinoma. Primary prevention of HBV infection is based on effective and safe vaccination, which also prevents hepatitis D virus infection.
The hepatitis B vaccine has been in use for more than forty years. Therefore, this review aims to present the available scientific evidence on the efficacy and safety of hepatitis B vaccination, with particular emphasis on findings from systematic reviews and meta-analyses, including current vaccination guidelines for the general population and high- groups, existing knowledge regarding the duration of vaccine-induced immune response, as well as the clinical and economic benefits of hepatitis B vaccination.

Keywords

hepatitis B vaccine; efficacy; safety; CpG-1018; immunization

Hrčak ID:

350073

URI

https://hrcak.srce.hr/350073

Publication date:

10.7.2026.

Article data in other languages: croatian

Visits: 0 *